Related Experiment Videos
Drug disposition analysis: a comparison between budesonide and fluticasone
1AstraZeneca R&D Lund, S-221 87 Lund, Sweden. anders.kallen@astrazeneca.com
Journal of Pharmacokinetics and Pharmacodynamics
|December 3, 2003
Summary
Drug disposition analysis reveals differences in how budesonide and fluticasone propionate distribute and eliminate. Fluticasone propionate, despite lower plasma levels, remains in the body longer, highlighting distinct pharmacokinetic profiles.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Glucocorticosteroid Drug Analysis
Background:
- Standard drug characterization relies on clearance and distributional volumes.
- Glucocorticosteroids like budesonide and fluticasone propionate exhibit known differences in disposition.
Purpose of the Study:
- To refine drug characterization using drug disposition analysis.
- To compare the distribution and elimination of budesonide and fluticasone propionate.
- To provide a detailed description of known differences in distributional volumes.
Main Methods:
- Application of drug disposition analysis.
- Utilizing concepts such as mean residence time and fraction of dose outside the central compartment.
- Comparative analysis of two glucocorticosteroids: budesonide and fluticasone propionate.
Main Results:
- Drug disposition analysis provides a more detailed understanding of distributional volume differences.
- Fluticasone propionate demonstrates prolonged residence in the body.
- Significant quantities of fluticasone propionate remain in the body despite lower observed plasma concentrations.
Conclusions:
- Drug disposition analysis offers enhanced characterization of drug distribution and elimination.
- Fluticasone propionate exhibits a distinct pharmacokinetic profile with prolonged body residence.
- Understanding these dispositional differences is crucial for effective glucocorticosteroid therapy.